Online Ahead of Print

 

FDA Paclitaxel Safety Panel Preview

An interview with FDA CDRH representatives discussing the upcoming advisory panel meeting to review concerns and current data on paclitaxel-eluting device use.

News

 

Thrombolex Receives FDA Clearance for Bashir Endovascular Catheters

May 13, 2019 -- Thrombolex, Inc. announced FDA 510(k) clearance for the Bashir endovascular catheter (BEC) and the Bashir N-X endovascular catheter (BEC N-X). The BEC and BEC …

FDA Approves Gore's TAG Conformable Thoracic Stent Graft With Active Control

May 15, 2019 -- Gore & Associates announced that the FDA has approved the company's TAG conformable thoracic stent graft with Active Control system for thoracic endova…

Eximo Medical's B-Laser Atherectomy System Successfully Used to Cross CTOs Without a Guidewire

May 13, 2019 -- Eximo Medical Ltd. announced the first successful use of the company's B-Laser atherectomy system in a step-by-step approach (eg, crossing a noncrossable c…

Balt's Titan Aspiration Catheter Receives CE Mark Approval

May 13, 2019 -- Balt USA, LLC announced that it has obtained European CE Mark approval for its Titan aspiration catheter. The Titan catheter line consists of a highly navigabl…

SVS Announces New Global Guideline on Chronic Limb-Threatening Ischemia

May 13, 2019 -- The Society for Vascular Surgery (SVS) announced that a global guideline on managing chronic limb-threatening ischemia (CLTI) will be published as a supplement…

Initial Experience Reported With Viabahn VBX as Bridging Stent Graft for Branched and Fenestrated EVAR

May 9, 2019 -- Online in Vascular and Endovascular Surgery, Sebastian Mafeld, MBBS, et al published findings from the initial experience with the balloon-expandable, heparin-b…

Click here for more News coverage

Paclitaxel In PAD

Current Supplement

Sponsored by Boston Scientific

Optimizing Embolic Therapy in Challenging Cases

Current European Supplement

Sponsored by EUMEDICA

Thrombolysis for Peripheral Arterial Thrombosis

Leading French experts discuss the place of thrombolysis in the modern era.

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 

Featured Center

 

Embolization

 
Vascular Market Price  Change
Abbott Laboratories $75.77  -0.26%
AstraZeneca PLC $37.54  -0.64%
Avinger $0.50  1.83%
Becton Dickinson and Co $229.36  0.44%
Boston Scientific Corporation $37.29  -0.08%
Cardinal Health $45.98  2.11%
Cardiovascular Systems Inc. $39.27  -0.68%
Edwards Lifesciences Corp. $172.78  -0.20%
Endologix Inc. $6.85  -1.44%
Johnson and Johnson $138.42  -0.14%
Vascular Market Price  Change
Medtronic, Inc. $87.57  -0.18%
Merit Medical Systems, Inc. $53.97  -1.68%
Penumbra, Inc. $139.05  -2.40%
Philips $40.19  -0.42%
Ra Medical Systems $4.77  -0.63%
Silk Road Medical $46.54  -0.19%
Stryker $184.31  0.09%
Teleflex Inc. $291.73  -1.44%
The Medicines Company $34.23  3.76%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.